Experimental browser for the Atmosphere
NEW: The FDA has been meeting with OpenAI to discuss the agency’s use of AI, according to sources with knowledge of the meetings. The meetings appear to be part of a broader effort at the FDA to use this technology to speed up the drug approval process.
May 7, 2025, 8:01 PM
{ "uri": "at://did:plc:inz4fkbbp7ms3ixufw6xuvdi/app.bsky.feed.post/3lom6tbalxk27", "cid": "bafyreigyd7ea3hel3rzblt7xqdglcw5ppowyilhg74gccr435pxpc73lna", "value": { "text": "NEW: The FDA has been meeting with OpenAI to discuss the agency’s use of AI, according to sources with knowledge of the meetings. \n\nThe meetings appear to be part of a broader effort at the FDA to use this technology to speed up the drug approval process.", "$type": "app.bsky.feed.post", "embed": { "$type": "app.bsky.embed.external", "external": { "uri": "https://www.wired.com/story/openai-fda-doge-ai-drug-evaluation/", "thumb": { "$type": "blob", "ref": { "$link": "bafkreidculcut3vonlefd3yhedsigjr37onhcr6xrb5osc5zx3s44ovdti" }, "mimeType": "image/jpeg", "size": 470199 }, "title": "OpenAI and the FDA Are Holding Talks About Using AI In Drug Evaluation", "description": "High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT." } }, "langs": [ "en" ], "createdAt": "2025-05-07T20:01:21.583Z" } }